Purpose
to develop lower cost API syntheses for global heath products. Within the scope of this grant, the global health products of interest for lowering API costs are (1) lenacapavir, (2) delamanid, (3) ganaplacide (KAF-156) and quabodepistat
Grantee
Division
Global Health
Date
APRIL 2025
Region served
GLOBAL
Committed amount
$450,000
Grant topic
Development of Solutions to Improve Global Health
Duration (months)
21
Grantee location
Ithaca, New York, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.